Josh B.

Josh B. is an experienced finance professional currently serving as Controller at Mirador Therapeutics since September 2024. Prior to this role, Josh held the position of Sr. Director, Corporate Controller at Escient Pharmaceuticals, a biotechnology company specializing in therapeutics for neurosensory-inflammatory disorders. Josh's previous experience includes serving as Controller at Metacrine, Inc., a biopharmaceutical company focused on liver and gastrointestinal diseases, and as SEC Reporting Manager at GenMark Diagnostics, which specializes in molecular diagnostic solutions. Earlier career stages included various roles at EY, culminating in Assurance Manager, and a finance internship at CyraCom International. Josh holds a Master of Science in Accounting from the University of Virginia and a Bachelor of Science in Business Administration, Accounting from the University of Arizona.